These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33934376)

  • 1. Serum-soluble PD-L1 may be a potential diagnostic biomarker in sepsis.
    Sun S; Chen Y; Liu Z; Tian R; Liu J; Chen E; Mao E; Pan T; Qu H
    Scand J Immunol; 2021 Jul; 94(1):e13049. PubMed ID: 33934376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Programmed Cell Death 1/Programmed Death Ligand 1 (PD-1/PD-L1) Axis in Sepsis-Induced Apoptosis.
    Coman O; Grigorescu BL; Huțanu A; Bacârea A; Văsieșiu AM; Fodor RȘ; Stoica F; Azamfirei L
    Medicina (Kaunas); 2024 Jul; 60(7):. PubMed ID: 39064603
    [No Abstract]   [Full Text] [Related]  

  • 3. Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome.
    Derigs M; Heers H; Lingelbach S; Hofmann R; Hänze J
    Immunol Res; 2022 Oct; 70(5):698-707. PubMed ID: 35732880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased percentage of PD-L1
    Jiang W; Li X; Wen M; Liu X; Wang K; Wang Q; Li Y; Zhou M; Liu M; Hu B; Zeng H
    Crit Care; 2020 Oct; 24(1):617. PubMed ID: 33076951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of Soluble Programmed Death-1 for Severe Sepsis and Septic Shock During the First Week in an Intensive Care Unit.
    Zhao Y; Jia Y; Li C; Shao R; Fang Y
    Shock; 2019 Mar; 51(3):289-297. PubMed ID: 29702526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma.
    Cho I; Lee H; Yoon SE; Ryu KJ; Ko YH; Kim WS; Kim SJ
    BMC Cancer; 2020 Feb; 20(1):120. PubMed ID: 32054467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomas.
    Zhang X; Liu L; Zhou S; Zhao K; Song Z; Hu G; Zhang T; Li Y; Qiu L; Li L; Qian Z; Meng B; Pan Y; Ren X; Wang X; Zhang H; Fu K
    Hematol Oncol; 2019 Aug; 37(3):270-276. PubMed ID: 31074879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum soluble PD-1 plays a role in predicting infection complications in patients with acute pancreatitis.
    Yu X; Pan Y; Fei Q; Lin X; Chen Z; Huang H
    Immun Inflamm Dis; 2021 Mar; 9(1):310-318. PubMed ID: 33417300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The content of the soluble forms PD-1 and PD-L1 in blood serum of patients with gastric cancer and their relationship with clinical and morphological characteristics of the disease.].
    Gershtein ES; Ognerubov NA; Chang VL; Delektorskaya VV; Korotkova EA; Sokolov NY; Polikarpova SB; Stilidi IS; Kushlinskii NE
    Klin Lab Diagn; 2020; 65(6):347-352. PubMed ID: 32459892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
    Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637
    [No Abstract]   [Full Text] [Related]  

  • 11. [Expression of soluble programmed death-1, soluble programmed death ligand 1 proteins and immune status in patients with oral lichen planus].
    Luo L; Shu M; Li S; Cai Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Oct; 50(10):585-9. PubMed ID: 26757624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen Saturation on Admission Is a Predictive Biomarker for PD-L1 Expression on Circulating Monocytes and Impaired Immune Response in Patients With Sepsis.
    Avendaño-Ortiz J; Maroun-Eid C; Martín-Quirós A; Lozano-Rodríguez R; Llanos-González E; Toledano V; Gómez-Campelo P; Montalbán-Hernández K; Carballo-Cardona C; Aguirre LA; López-Collazo E
    Front Immunol; 2018; 9():2008. PubMed ID: 30233593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk stratification and prognostic evaluation of soluble programmed death-1 on patients with sepsis in emergency department.
    Zhao Y; Jia Y; Li C; Fang Y; Shao R
    Am J Emerg Med; 2018 Jan; 36(1):43-48. PubMed ID: 28716595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression.
    Shigemori T; Toiyama Y; Okugawa Y; Yamamoto A; Yin C; Narumi A; Ichikawa T; Ide S; Shimura T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; Kusunoki M
    Ann Surg Oncol; 2019 Mar; 26(3):876-883. PubMed ID: 30565045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer.
    Okuma Y; Wakui H; Utsumi H; Sagawa Y; Hosomi Y; Kuwano K; Homma S
    Clin Lung Cancer; 2018 Sep; 19(5):410-417.e1. PubMed ID: 29859759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PREDICTIVE VALUE OF SOLUBLE PROGRAMMED CELL DEATH LIGAND-1 IN THE PROGRESSION OF SEPTIC PATIENTS TO CHRONIC CRITICAL ILLNESS IN THE INTENSIVE CARE UNIT: A PROSPECTIVE OBSERVATIONAL CLINICAL STUDY.
    Zeng C; Li X; Lu Z; Mu G; Deng Y
    Shock; 2023 Aug; 60(2):163-171. PubMed ID: 37267247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
    Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: Association with activity and severity.
    Du Y; Nie L; Xu L; Wu X; Zhang S; Xue J
    Scand J Immunol; 2020 Jul; 92(1):e12884. PubMed ID: 32243638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Host Immune Response Trajectories Among Hospitalized Patients With Sepsis.
    Yende S; Kellum JA; Talisa VB; Peck Palmer OM; Chang CH; Filbin MR; Shapiro NI; Hou PC; Venkat A; LoVecchio F; Hawkins K; Crouser ED; Newman AB; Angus DC
    JAMA Netw Open; 2019 Aug; 2(8):e198686. PubMed ID: 31390038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of the levels of soluble forms of receptor and ligand of the immunity control point PD-1/PD-L1 in the blood serum of patients with typical bone osteosarcoma and chondrosarcoma.
    Kushlinskii NE; Alferov AA; Boulytcheva IV; Timofeev YS; Korotkova EA; Khvan OT; Kuzmin YB; Kuznetsov IN; Bondarev AV; Shchupak MY; Sokolov NY; Efimova MM; Gershtein ES; Sushentsov EA; Aliev MD; Musaev ER
    Klin Lab Diagn; 2020 Dec; 65(11):669-675. PubMed ID: 33301655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.